Lead sponsor
Verdiva Bio Dev Limited
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
3
Active
662
Total enrollment
36
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
2
Trials by status
Not yet recruiting
2
Active, not recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or OverweightHbA1c ≤6.4%Ph 1Not yet recruiting336